TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta
EMBO Molecular Medicine · 2023
DOI: 10.15252/emmm.202317528 ↗Kurz gefasst
Leserbrief in der Zeitschrift EMBO Molecular Medicine, 2023. Verfasst von Julia Etich und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Department of Orthopedics (Friedrichsheim), University Hospital Frankfurt, Goethe University F…. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Deutsche Forschungsgemeinschaft, UKRI|Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Osteogenesis imperfecta (OI) is a hereditary skeletal disorder primarily affecting collagen type I structure and function, causing bone fragility and occasionally versatile extraskeletal symptoms. This study expands the spectrum of OI-causing TAPT1 mutations and links extracellular matrix changes to signaling regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Department of Orthopedics (Friedrichsheim), University Hospital Frankfurt, Goethe University Frankfurt/Main, Frankfurt, Germany.
- Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany.
- Center for Family Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Cell Biology Laboratories, School of Biochemistry, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, UK.
- Biochemistry Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
ORCID-Profile: Julia Etich, Oliver Semler, Nicola L Stevenson, Alice Stephan, Roberta Besio, Nadia Garibaldi, Nadine Reintjes, Max Christoph Liebau, Antonella Forlino, David J Stephens, Christian Netzer, Frank Zaucke, Mirko Rehberg
Förderung
- Biotechnology and Biological Sciences Research Council
- Deutsche Forschungsgemeinschaft
- UKRI|Biotechnology and Biological Sciences Research Council
Zitieren
APA
Etich, J., Semler, O., Stevenson, N. L., Stephan, A., Besio, R., Garibaldi, N., Reintjes, N., Dafinger, C., Liebau, M. C., Baumann, U., Mörgelin, M., Forlino, A., Stephens, D. J., Netzer, C., Zaucke, F., & Rehberg, M. (2023). TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202317528
Vancouver
Etich J, Semler O, Stevenson NL, Stephan A, Besio R, Garibaldi N, et al. TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta. EMBO Molecular Medicine. 2023. doi:10.15252/emmm.202317528
BibTeX
@article{Etich2023,
author = {Etich, Julia and Semler, Oliver and Stevenson, Nicola L and Stephan, Alice and Besio, Roberta and Garibaldi, Nadia and Reintjes, Nadine and Dafinger, Claudia and Liebau, Max Christoph and Baumann, Ulrich and Mörgelin, Matthias and Forlino, Antonella and Stephens, David J and Netzer, Christian and Zaucke, Frank and Rehberg, Mirko},
title = {TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta},
journal = {EMBO Molecular Medicine},
year = {2023},
doi = {10.15252/emmm.202317528}
}
EUVIMED